Why should breast surgeons use ultrasound? M. AhmedN. AbdullahM. Douek Editorial 05 April 2014 Pages: 1 - 4
Nicotine promotes apoptosis resistance of breast cancer cells and enrichment of side population cells with cancer stem cell-like properties via a signaling cascade involving galectin-3, α9 nicotinic acetylcholine receptor and STAT3 Prasun GuhaGargi BandyopadhyayaHafiz Ahmed Preclinical Study 26 March 2014 Pages: 5 - 22
MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis Fan YangXingchun ZhouJianlin Yuan Preclinical study Open access 01 April 2014 Pages: 23 - 32
HER2/HER3 heterodimers and p21 expression are capable of predicting adjuvant trastuzumab response in HER2+ breast cancer Andrew R. GreenFabrício F. T. BarrosIan O. Ellis Preclinical study Open access 06 April 2014 Pages: 33 - 44
Discovery of structure-based small molecular inhibitor of αB-crystallin against basal-like/triple-negative breast cancer development in vitro and in vivo Zhijuan ChenQing RuanJun Cai Preclinical Study 08 April 2014 Pages: 45 - 59
Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer Martin SjöströmLinda HartmanMårten Fernö Preclinical study 09 April 2014 Pages: 61 - 71
C–X–C ligand 10 and C–X–C receptor 3 status can predict tamoxifen treatment response in breast cancer patients Erik HilbornTove SivikAgneta Jansson Preclinical Study Open access 09 April 2014 Pages: 73 - 82
Examining and predicting drug preferences of patients with metastatic breast cancer: using conjoint analysis to examine attributes of paclitaxel and capecitabine Mary Lou SmithCarol B. WhiteGeorge W. Sledge Jr. Clinical trial 20 March 2014 Pages: 83 - 89
Diagnostic performance of breast-specific gamma imaging in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients Hyo Sang LeeBeom Seok KoDae Hyuk Moon Clinical trial 27 March 2014 Pages: 91 - 100
Expression of organic anion-transporting polypeptide 1A2 and organic cation transporter 6 as a predictor of pathologic response to neoadjuvant chemotherapy in triple negative breast cancer Yumi HashimotoShigenobu TatsumiShingo Kamoshida Clinical trial 27 March 2014 Pages: 101 - 111
What lies behind chemotherapy-induced amenorrhea for breast cancer patients: a meta-analysis Jianli ZhaoJieqiong LiuFengxi Su Clinical trial 27 March 2014 Pages: 113 - 128
Accuracy of ultrasound-guided breast-conserving surgery in the determination of adequate surgical margins Holm EggemannTanja IgnatovAtanas Ignatov Clinical Trial 29 March 2014 Pages: 129 - 136
Additional value of F-18 FDG PET/CT for initial staging in breast cancer with clinically negative axillary nodes Young Jin JeongDo-Young KangHye Joo Son Clinical trial 30 March 2014 Pages: 137 - 142
Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study) M. TakadaH. IshiguroM. Toi Clinical trial 30 March 2014 Pages: 143 - 153
Health-related quality of life and psychological distress during neoadjuvant endocrine therapy with letrozole to determine endocrine responsiveness in postmenopausal breast cancer Naruto TairaHiroji IwataYasuo Ohashi Clinical trial 02 April 2014 Pages: 155 - 164
Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case–control studies Amy Trentham-DietzBrian L. SpraguePolly A. Newcomb Epidemiology 20 March 2014 Pages: 165 - 175
Differences in biological features of breast cancer between Caucasian (Italian) and African (Tanzanian) populations D. AmadoriP. SerraN. Masalu Epidemiology 23 March 2014 Pages: 177 - 183
Impact of comorbidity on outcome of older breast cancer patients: a FOCUS cohort study Mandy KiderlenNienke A. de GlasGerrit-Jan Liefers Epidemiology 28 March 2014 Pages: 185 - 192
HER2 and TOP2A amplification in a hospital-based cohort of breast cancer patients: associations with patient and tumor characteristics Peter A. FaschingSebastian WeihbrechtMichael F. Press Epidemiology 29 March 2014 Pages: 193 - 203
Contribution of problem-solving skills to fear of recurrence in breast cancer survivors Tatuo AkechiKanae MominoHiroji Iwata Epidemiology 30 March 2014 Pages: 205 - 210
Older women’s experience with breast cancer treatment decisions Mara A. SchonbergRobyn L. BirdwellRebecca A. Silliman Epidemiology 31 March 2014 Pages: 211 - 223
Association between cadmium and breast cancer risk according to estrogen receptor and human epidermal growth factor receptor 2: epidemiological evidence Loreta StrumylaiteRima KregzdyteDarius Pranys Epidemiology 02 April 2014 Pages: 225 - 232
Long-term risk of medical conditions associated with breast cancer treatment Deirdre A. HillNora K. HorickDianne M. Finkelstein Epidemiology 03 April 2014 Pages: 233 - 243
Genetic heterogeneity beyond CYP2C8*3 does not explain differential sensitivity to paclitaxel-induced neuropathy Daniel L. HertzSiddharth RoyHoward L. McLeod Epidemiology 06 April 2014 Pages: 245 - 254
Premenopausal dietary fat in relation to pre- and post-menopausal breast cancer Maryam S. FarvidEunyoung ChoWalter C. Willett Epidemiology 10 April 2014 Pages: 255 - 265
